Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
about
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisClinical relevance of brain volume measures in multiple sclerosis.MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.Neurofunctional maps of the 'maternal brain' and the effects of oxytocin: a multimodal voxel-based meta-analysis.Thalamus pathology in multiple sclerosis: from biology to clinical application.Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis MethodPharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Non-Local Means Inpainting of MS Lesions in Longitudinal Image ProcessingBrain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.Abnormalities of regional brain function in Parkinson's disease: a meta-analysis of resting state functional magnetic resonance imaging studies.Multiple sclerosis, cannabis, and cognition: A structural MRI studyAnisotropic kernels for coordinate-based meta-analyses of neuroimaging studies.Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis.Meta-analysis of regional white matter volume in bipolar disorder with replication in an independent sample using coordinates, T-maps, and individual MRI data.Deep grey matter volume loss drives disability worsening in multiple sclerosis.Structural abnormalities and altered regional brain activity in multiple sclerosis with simple spinal cord involvement.Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.Structural correlates for fatigue in early relapsing remitting multiple sclerosis.Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.Gray matter abnormalities in pediatric autism spectrum disorder: a meta-analysis with signed differential mapping.MRI-Based Measurement of Brain Stem Cross-Sectional Area in Relapsing-Remitting Multiple Sclerosis.Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.Grey matter atrophy is associated with disability increase in natalizumab-treated patients.Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease.Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.
P2860
Q28080754-4DAE3F8D-307E-429A-8015-39D1E4F975C0Q30738659-98199633-5F8E-4D90-80E1-4CCEB53641E8Q30798662-AA607591-F1C5-4DAD-96D3-3BC5BF358670Q30801506-6BC1A2AC-4A0C-47EC-A35F-D2DDD6EF253AQ30871067-23CD847E-C506-4BDA-883D-7A536716258AQ30885558-C380B8DF-2E95-4FFE-81D0-84D06602AE14Q35143786-0796E934-96B9-4ADE-A925-572C78C2F15AQ35596118-20F845A2-59F3-45CA-BAEB-86F9FBAA7CADQ35888929-22CEB4A4-66C1-419C-81BD-72C1A530F299Q36353053-F84A45A5-3B88-4DD8-998F-9D29A2FEF8FFQ36369426-64328698-6752-4464-8C34-5BAFAFA974ACQ36590036-2EDB7630-6B0E-47EE-B6EA-7AC234F2ACE0Q37581547-F752A8AC-7485-47C3-AED4-30A76827C41AQ39187449-1E1C1887-CFB2-4356-BC9B-30D3E01BB8B5Q41939091-FB50F846-BE18-4F71-BF78-EE13D5EF19BFQ45787144-07B6F582-0E9C-45CA-A445-97E7EB5FC474Q46112792-04F6ED75-1CCD-47C9-BD85-1116FF8BE2ACQ47433505-F45000B2-EC34-40B8-9151-544EF0538311Q47866122-DF4C3B55-3E00-415C-8D29-6DA69DA6AA60Q47922798-9BB4E053-0387-4F03-A8EE-8ED6AFE69952Q47989756-322A441F-FB97-4BC7-8EA4-8B5A798B3891Q48081818-02FBEC8B-935F-40F9-ACE5-892295BEE904Q48160589-A2047DA2-AFCA-4FDA-858B-6A276D0EBB42Q48199092-BEDA5965-8F92-4308-93E9-BB58AF2599B4Q48199827-095C4691-B978-4A6F-85DA-7A694F95C341Q48220840-E5C3A81B-0305-4F58-9D2C-1505947525F3Q48221119-2A44D669-2A0D-4229-AFA6-D1BCDCC4A4D7Q48359324-2AEEDC07-63B6-4F40-8CAE-5D8EFBE615CBQ48651177-AFB90800-B7A8-4A29-ABF8-366BA92C183DQ49019280-6899945B-D70D-44B5-8FA8-0BC65FF659E3Q49247807-42A526EC-DDBD-4701-84C9-45E06464E001Q52145478-5A3F00EC-2A4D-4D7F-8802-1C8502C47110Q55502196-2CB87B23-BF5E-4BCB-A240-4F4A0C086B7B
P2860
Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Localized grey matter atrophy ...... ns with functional disability.
@en
type
label
Localized grey matter atrophy ...... ns with functional disability.
@en
prefLabel
Localized grey matter atrophy ...... ns with functional disability.
@en
P50
P1476
Localized grey matter atrophy ...... ons with functional disability
@en
P2093
P304
P356
10.1016/J.NEUBIOREV.2013.03.006
P577
2013-03-18T00:00:00Z